2022
DOI: 10.2139/ssrn.4249920
|View full text |Cite
|
Sign up to set email alerts
|

Predictors of and Factors Associated with Novel Post COVID Symptoms in the Musculoskeletal, Functional, and Cognitive Domains for Vaccinated Delta-Variant Survivors: A Descriptive Survey of a Nationwide Prospective Inception Cohort in Bangladesh

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

4
1

Authors

Journals

citations
Cited by 6 publications
(14 citation statements)
references
References 0 publications
1
7
0
Order By: Relevance
“…In Bangladesh, studies estimate that between 16 and 24% of those recovering from COVID-19 infection face long COVID [ 2 , 4 ]. The long COVID has a wide prevalence rate globally, ranging from 7 to 43% [ 2 – 4 ], and pain is one of the major long COVID symptoms [ 5 ].…”
Section: Introductionmentioning
confidence: 99%
“…In Bangladesh, studies estimate that between 16 and 24% of those recovering from COVID-19 infection face long COVID [ 2 , 4 ]. The long COVID has a wide prevalence rate globally, ranging from 7 to 43% [ 2 – 4 ], and pain is one of the major long COVID symptoms [ 5 ].…”
Section: Introductionmentioning
confidence: 99%
“…The global prevalence of Long COVID (LC) survivors varies between 10 to 36% [ 2 ]. A household survey reported the prevalence of LC in Bangladesh was 16.1% as of 2020 [ 3 ] and the rate increased to 25.2% in another survey [ 4 ]. A variety of symptoms were reported in both studies with major symptoms which included fatigue, musculoskeletal pain, headache, loss of concentration, anxiety, depression, and post-exertion dyspnea [ 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…A household survey reported the prevalence of LC in Bangladesh was 16.1% as of 2020 [ 3 ] and the rate increased to 25.2% in another survey [ 4 ]. A variety of symptoms were reported in both studies with major symptoms which included fatigue, musculoskeletal pain, headache, loss of concentration, anxiety, depression, and post-exertion dyspnea [ 3 , 4 ]. LC is not only a sequel of COVID-19, but also it has an unpredictable disease course that is evident to be extended to more than a year, and a variety of symptoms are prevalent with the changing of time [ 5 ].…”
Section: Introductionmentioning
confidence: 99%
“…1 Between 16.2% and 25.2% of Bangladeshi people are experiencing LCS. 2,3 The respondents reported a broad spectrum of LCS, those were reported as fatigue, musculoskeletal pain, headache, loss of concentration, anxiety, depression, and post-exertion dyspnea. The presentation of LCS was noted as a relapsing remittent nature, which might not be described as related to a single biological system or organ involvement in the human body.…”
Section: Introductionmentioning
confidence: 99%
“…6 In a lower middle-income country like Bangladesh, it is important to study symptom responses and impairments to determine the scope of rehabilitation and generate clinical trials and shreds of evidence. From recent studies in Bangladesh, 2,3 we understand the symptom responses, disease spectrum, and scope of rehabilitation but there are inconclusive answers on the rehabilitation interventions for LCS. From the fact sheets of WHO, we know rehabilitation interventions play an important for the clinical management of LCS.…”
Section: Introductionmentioning
confidence: 99%